Covidien, maker of ReliOn syringes, recalls 471,000 mislabeled insulin syringes. ReliOn disposable syringes sold at Wal-Mart and Sam’s Club can cause insulin overdose.
January 6, 2008, Dallas, TX(AmericanInjuryNews.com)–Enews defective medical supplies reporters and Dallas County product injury lawyers alert 471,000 disposable insulin syringes recalled. ReliOn U-40 disposable insulin syringes have been mistakenly labeled as U-100 syringes by the manufacturer. Patients using U-100 insulin syringes could experience a serious overdose by using the mislabeled U-40 disposable syringe. According to the syringe company, Covidien, and the U.S. Food and Drug Administration (FDA) www.fda.gov, the use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose of insulin. Insulin overdoses can lead to severe hypoglycemia and possibly death.
Enews mislabeled medical supplies correspondents with AIN and Dallas product injury attorneys reveal ReliOn disposable insulin syringes were sold only by Wal-Mart and Sam’s Club under the ReliOn name. The mislabeled U-40 syringes are manufactured by Covidien, formerly Tyco Health Care of Massachusetes. The following details about the recalled syringes are listed below and additional information can be found on www.fda.gov :
-Recalled lot is number 813900
-ReliOn insulin syringes labeled U-100 (actually U-40)
-ReliOn insulin syringes are 1 cc and 31 gauge needles
-Sold only by Wal-Mart and Sam’s Club
-Sold from August 1 to October 8, 2008
Enews product safety advocates and Dallas, Texas product injury attorneys are urging all healthcare professionals, patients, and consumers to check their supplies of U-100 insulin syringes for the recalled products. DO NOT USE THESE SYRINGES! The recalled syringes can be returned to Wal-Mart or Sam’s Club for replacement. If you have been injured by a defective product or because your medical supplies were labeled incorrectly you may be entitled to compensation for your injuries and damages.
About AmericanInjuryNews.com (AIN)–This web site visibility medium offers attorneys, freelance writers, journalists and other business professionals the ability to reach members of their local and national communities quickly and easily. Information regarding FDA medical device alerts and recalls, product liability lawsuits, defective medical supplies litigation, harmful drug suits, wrongful death cases, and medical negligence legal actions.